title: From research to the real world: buprenorphine in the decade of the Clinical Trials Network.
authors.affiliation: Pacific Region Node, University of California, Los Angeles, USA.
authors.forename: Walter
authors.initials: W
authors.lastname: Ling
authors.forename: Petra
authors.initials: P
authors.lastname: Jacobs
authors.forename: Maureen
authors.initials: M
authors.lastname: Hillhouse
authors.forename: Albert
authors.initials: A
authors.lastname: Hasson
authors.forename: Christie
authors.initials: C
authors.lastname: Thomas
authors.forename: Thomas
authors.initials: T
authors.lastname: Freese
authors.forename: Steven
authors.initials: S
authors.lastname: Sparenborg
authors.forename: Dennis
authors.initials: D
authors.lastname: McCarty
authors.forename: Roger
authors.initials: R
authors.lastname: Weiss
authors.forename: Andrew
authors.initials: A
authors.lastname: Saxon
authors.forename: Allan
authors.initials: A
authors.lastname: Cohen
authors.forename: Michele
authors.initials: M
authors.lastname: Straus
authors.forename: Gregory
authors.initials: G
authors.lastname: Brigham
authors.forename: David
authors.initials: D
authors.lastname: Liu
authors.forename: Paul
authors.initials: P
authors.lastname: McLaughlin
authors.forename: Betty
authors.initials: B
authors.lastname: Tai
mesh_terms: D000286:Administration, Sublingual; D002047:Buprenorphine / Q000009:adverse effects / Q000627:therapeutic use*; D000069479:Buprenorphine, Naloxone Drug Combination; D002986:Clinical Trials as Topic; D003153:Community Health Services / Q000379:methods; D004338:Drug Combinations; D006801:Humans; D009270:Naloxone / Q000009:adverse effects / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D009294:Narcotics / Q000009:adverse effects / Q000627:therapeutic use; D054577:National Institute on Drug Abuse (U.S.); D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D017450:Receptors, Opioid, mu / Q000819:agonists; D014481:United States
chemical_list: D000069479:Buprenorphine, Naloxone Drug Combination; D004338:Drug Combinations; D009292:Narcotic Antagonists; D009294:Narcotics; D017450:Receptors, Opioid, mu; D009270:Naloxone; D002047:Buprenorphine